Article
Ursodeoxycholic acid (UDCA) mitigates the host inflammatory response during <i>Clostridioides difficile</i> infection by altering gut bile acids which attenuates NF-κB signaling via bile acid activated receptors
2020-01-21
Abstract excerpt
Clostridioides difficile infection (CDI) is associated with increasing morbidity and mortality posing an urgent threat to public health. Recurrence of CDI after successful treatment with antibiotics is high, thus necessitating discovery of novel therapeutics against this enteric pathogen. Administration of the secondary bile acid ursodeoxycholic acid (UDCA, ursodiol) inhibits the life cycle of various strains of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fff66b8a-e878-5190-98e9-678ccfdf7d00
- DOI
- 10.1101/2020.01.16.910018
